In the field of cell biology, the method of partial cloning (PCL) converts a fully differentiated old somatic cell into a partially reprogrammed young cell that retains all the specialised functions of the differentiated old cell but is simply younger. The method of PCL reverses characteristics associated with old cells. For example, old, senescent, cells rejuvenated by PCL are free of highly condensed senescence-associated heterochromatin foci (SAHF) and re-acquire the proliferation potential of young cells. The method of PCL thus rejuvenates old cells without de-differentiation and passage through an embryonic, pluripotent, stage.
PCL consists in introducing a somatic adult or senescent cell nucleus or entire cell with enlarged membrane pores in an (activated) oocyte and to withdraw this treated cell before its de-differentiation and first cell division occurs. Thus, the progressive rejuvenation capability of the oocyte is used only temporarily in order to obtain a partial natural rejuvenation. PCL permits to envisage a chosen degree of partial rejuvenation in changing the duration of the introduction of the treated cell in the oocyte. Using PCL cell de-differentiation and its age reprogramming might be, at least partially, separable. Thus the existence of an isolated ageing clock would be confirmed at least during a certain part of the cellular evolution and involution.
First experimental result shows a possible high efficiency in partial rejuvenation of senescent mouse cells. Notably PCL rejuvenates exclusively one single tissue or organ, in contrast to classical cloning PCL is therefore unable to reconstitute an entire organism. Furthermore, PCL is feasible in a few hours in opposition to classical cloning or induced pluripotent stem cells (iPS) which all need weeks or months.
Classical cloning can rejuvenate old cells but the process demands that the old cells must artificially pass through an embryonic cell stage. Partial cloning affords the advantage that the old cells to be rejuvenated do not have to pass through the embryonic cell stage and are simply made younger.
The key notion that exemplifies “partial” cloning from “classical” cloning is the separation of the mechanism(s) that “wipe clean” the specialization of a cell from those that “wipe-clean” the age of the cell. In short, partial cloning aims to retain the specialized functions of a cell and simply make it younger, e.g., a skin cell is rejuvenated without having to pass through the embryonic stage that is a must for rejuvenation via the classical cloning technique (see diagram).
In a new laboratory at the Forschungszentrum Borstel our work on partial cloning focuses, inter alia, on the restricted, temporary, incubation of an “old” cell within the egg. In this way only the age of the cell is “wiped clean” and its specialized, differentiated, state is retained. It is simply made younger – rejuvenated - without going through the embryonic state. The measure of Diagram showing the difference between “Classical” and “Partial” cloning: Classical cloning (the route given by the black arrows) can rejuvenate an old cell but requires passage through an embryonic stage. “Partial cloning” (given by the red arrow) rejuvenates old cells without passage through an embryonic stage.“Partial cloning” (given by the red arrow)rejuvenates old cells without passage through an embryonic stage. In a new laboratory at the Forschungszentrum Borstel our work on partial cloning focuses, inter alia, on the restricted, temporary, incubation of an “old” cell within the egg. In this way only the age of the cell is “wiped clean” and its specialized, differentiated, state is retained. It is simply made younger – rejuvenated - without going through the embryonic state. The measure of rejuvenation in our system is, first, the re-acquisition of the ability of an old cell to divide, something that is lost in old cells and, second, the loss of characteristics that are associated with old cells.
Should such rejuvenation be achievable the consequences for medicine would be profound. It would avoid the need to artificially pass through an embryonic stage – either by nuclear transfer or by the so-called iPS cells method - to rejuvenate cells. One would simply be able to take aged cells from a patient and then return to the patient their own, histocompatible, rejuvenated heart cells, liver cells etc. In sharp contrast to the cycle of artificial de-differentiation of somatic cells to stem cells and then the artificial re-differentiation of stem cells to the desired differentiated cell type, which is highly inefficient, time-consuming and results in unstable cell types. The process of partial cloning would be efficient and rapid and thus cheap both in terms of materials and manpower. In short, partial cloning has enormous potential to relieve human suffering and disease: it is the most rapid and cheap route to successful regenerative medicine. Partial cloning also avoids the ethical problems associated with “classical” cloning in that it does not result in live born – it mere uses the oocyte briefly as a means to condition and thereby rejuvenate the old cell exclusively.
- Singh PB, Zacouto F (June 2010). "Nuclear reprogramming and epigenetic rejuvenation" (PDF). J. Biosci. 35 (2): 315–9. doi:10.1007/s12038-010-0034-2. PMID 20689186.
- Adams PD (August 2007). "Remodeling of chromatin structure in senescent cells and its potential impact on tumor suppression and aging". Gene. 397 (1–2): 84–93. doi:10.1016/j.gene.2007.04.020. PMC 2755200. PMID 17544228.
- Chan EM, Ratanasirintrawoot S, Park IH, Manos PD, Loh YH, Huo H, Miller JD, Hartung O, Rho J, Ince TA, Daley GQ, Schlaeger TM (November 2009). "Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells". Nat. Biotechnol. 27 (11): 1033–7. doi:10.1038/nbt.1580. PMID 19826408.
- Hanna J, Markoulaki S, Mitalipova M, Cheng AW, Cassady JP, Staerk J, Carey BW, Lengner CJ, Foreman R, Love J, Gao Q, Kim J, Jaenisch R (June 2009). "Metastable pluripotent states in NOD-mouse-derived ESCs". Cell Stem Cell. 4 (6): 513–24. doi:10.1016/j.stem.2009.04.015. PMC 2714944. PMID 19427283.
- Hanna J, Saha K, Pando B, van Zon J, Lengner CJ, Creyghton MP, van Oudenaarden A, Jaenisch R (December 2009). "Direct cell reprogramming is a stochastic process amenable to acceleration". Nature. 462 (7273): 595–601. doi:10.1038/nature08592. PMC 2789972. PMID 19898493.